Akili (AKLI) News Today → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free AKLI Stock Alerts $0.23 -0.01 (-4.18%) (As of 04/22/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDigital medicine maker Akili slashed executive pay in 2023bizjournals.com - March 11 at 6:12 PMAkili Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - March 3 at 11:34 AMAkili (AKLI) Gets a Buy from TD Cowenmarkets.businessinsider.com - March 1 at 11:12 PMAkili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updatebusinesswire.com - February 29 at 4:01 PMPreview: Akili's Earningsbenzinga.com - February 28 at 5:47 PMAkili's ADHD digital therapy seeks Japan approvalinvesting.com - February 28 at 12:47 PMCrude Oil Gains 1%; US New Home Sales Increase In Januarymsn.com - February 27 at 10:43 AMPureTech Founded Entity Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx ® for Pediatric ADHD Patients in Japanbusinesswire.com - February 27 at 2:00 AMWhy Is Akili (AKLI) Stock Up 110% Today?investorplace.com - February 26 at 1:51 PMWhy Is Prescription Digital Medicine-Focused Akili Stock Trading Over 100% On Monday?msn.com - February 26 at 1:07 PMAkili's ADHD device submitted for Japanese approval, stock rallies 130%seekingalpha.com - February 26 at 1:07 PMAkili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japanfinance.yahoo.com - February 26 at 1:07 PMAkili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx® for Pediatric ADHD Patients in Japanbusinesswire.com - February 26 at 8:47 AMAkili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance Updatesfinance.yahoo.com - February 21 at 9:30 PMAkili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance Updatesbusinesswire.com - February 21 at 4:05 PMAkili, Inc. (AKLI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?finance.yahoo.com - January 15 at 3:28 PMAkli Tadjer: French writer meets students in school race rowbbc.com - January 8 at 4:45 PMWhat to Know About EndeavorRX, the Video Game to Treat ADHDcnet.com - December 26 at 11:10 PMAkili, Inc. (AKLI) Upgraded to Buy: Here's What You Should Knowfinance.yahoo.com - December 21 at 2:37 PMThe Petri Dish: ADHD-treating videogame cleared for teens, CRISPR exec resignsbizjournals.com - December 21 at 9:37 AMAkili Inc Ordinary Sharesmorningstar.com - December 19 at 8:13 PMEndeavorRxⓇ, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17finance.yahoo.com - December 18 at 1:02 PMAnalysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN) and Akili (AKLI)markets.businessinsider.com - November 15 at 9:49 AMAkili Inc Ordinary Shares AKLImorningstar.com - November 14 at 2:11 PMAkili, Inc. (NASDAQ:AKLI) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 13 at 2:31 PMAkili Reports Third Quarter 2023 Financial Results and Provides Business Updatefinanznachrichten.de - November 10 at 8:13 AMEmployees with ADHD Aren't Reaching Their Full Potential at Work, Akili Study Findstmcnet.com - October 14 at 10:37 AMEmployees with ADHD Aren’t Reaching Their Full Potential at Work, Akili Study Findsfinance.yahoo.com - October 12 at 10:22 AMAkili Announces Leadership Transitionfinance.yahoo.com - October 6 at 9:42 AMAnalyst Affirms Buy Rating for Akili, Emphasizing Shift to OTC Strategy and Potential Strategic Partnershipsmarkets.businessinsider.com - October 5 at 6:51 PMBuy Rating on Akili’s Stock: Strategic Shift, Cash Management, and Anticipated FDA Clearances Bolster Optimismmarkets.businessinsider.com - October 2 at 8:02 PMAkili Releases EndeavorOTC(TM) on Android(TM) Devices, Expanding Treatment Access for Millions of Adults with ADHDstockhouse.com - September 21 at 9:47 AMInsider Sell: CEO Martucci Walter Edward II Sells 2,353 Shares of Akili Incfinance.yahoo.com - September 15 at 8:33 AMAkili Announces Business Transformation, Focusing on Non-prescription Modelfinance.yahoo.com - September 13 at 6:59 PMAkili Plans To Transform To Non-prescription Model; To Cut Workforce By Approx. 40%markets.businessinsider.com - September 13 at 6:59 PMmarketbeat.com - September 13 at 7:57 AMAkili, Inc. (NASDAQ:AKLI) Q2 2023 Earnings Call Transcriptinsidermonkey.com - August 14 at 1:01 PMAkili, Inc. reports Q2 resultsmsn.com - August 10 at 4:57 PMAkili to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 10 at 4:30 p.m. ETfinance.yahoo.com - July 10 at 11:17 AMAkili (AKLI) Receives a Buy from LifeSci Capitalmarkets.businessinsider.com - June 10 at 1:58 PMEndeavorOTC Elevates ADHD Treatment: Unprecedented Mobile Game Therapy for Adultsfinance.yahoo.com - June 8 at 4:51 PMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Bausch Health Companies (BHC), PTC Therapeutics (PTCT) and Akili (AKLI)markets.businessinsider.com - May 18 at 6:42 AMAkili Reports First Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - May 11 at 8:18 PMAkili (AKLI) Gets a Buy from LifeSci Capitalmarkets.businessinsider.com - May 3 at 10:51 PMGame-Changing ADHD Treatment: Akili's EndeavorRx Shows Significant Improvement in Adult Attention Functioningfinance.yahoo.com - May 3 at 5:51 PMAkili stock surges ~40% after video game EndeavorRx shows benefit in ADHD adultsmsn.com - May 3 at 12:51 PMWhy Is Akili (AKLI) Stock Up 21% Today?investorplace.com - May 3 at 12:02 PMAkili Stock (NASDAQ:AKLI), Dividendsbenzinga.com - April 30 at 1:49 PMAkili to Host First Quarter Financial Results Conference Call and Webcast on Thursday, May 11 at 4:30 p.m. ETfinance.yahoo.com - April 13 at 9:58 AMAkili, Inc. (NASDAQ:AKLI) Receives Average Recommendation of "Moderate Buy" from Brokeragesmarketbeat.com - April 7 at 4:18 AM Get Akili News Delivered to You Automatically Sign up to receive the latest news and ratings for AKLI and its competitors with MarketBeat's FREE daily newsletter. Email Address Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him AKLI Media Mentions By Week AKLI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKLI News Sentiment▼0.000.47▲Average Medical News Sentiment AKLI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKLI Articles This Week▼01▲AKLI Articles Average Week Get Akili News Delivered to You Automatically Sign up to receive the latest news and ratings for AKLI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: STRATA Skin Sciences News PAVmed News T2 Biosystems News Meihua International Medical Technologies News GlucoTrack News Nephros News Microbot Medical News NEXGEL News Getaround News PolyPid News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKLI) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akili, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
